Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Receptos, Inc. Stockholders
15 Julho 2015 - 7:34PM
Business Wire
Kirby McInerney LLP is investigating potential claims against
the Board of Directors of Receptos, Inc. (“Receptos” or the
“Company”) (NASDAQ:RCPT) concerning the proposed acquisition of the
Company by Celgene Corporation. Pursuant to the terms of the
definitive agreement, Receptos stockholders will receive $232.00 in
cash for each share of Receptos common stock they own, in a
transaction valued at approximately $7.2 billion.
The investigation concerns whether the Receptos Board of
Directors violated its fiduciary duties by agreeing to the proposed
transaction and whether the proposed consideration adequately
values the Company’s common stock.
If you are a Receptos stockholder and wish to obtain additional
information, please contact J. Brandon Walker, Esq. by email
at bwalker@kmllp.com, or telephone at (212) 699-1145 or toll free
at (888) 529-4787, or by filling out this contact form. There is no
cost or obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating
in securities, whistleblower, antitrust and consumer litigation.
For additional information, please go to www.kmllp.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150715006660/en/
Kirby McInerney LLPJ. Brandon Walker, Esq., (212) 699-1145toll
free: (888) 529-4787bwalker@kmllp.com
RECEPTOS, INC. (NASDAQ:RCPT)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
RECEPTOS, INC. (NASDAQ:RCPT)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024
Notícias em tempo-real sobre (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Receptos, Inc. (MM)